WHO ICTRP trial
A Clinical Study to evaluate Efficacy and Safety of Tapentadol Nasal Spray in…
CTRI/2019/03/018143 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2019/03/018143 |
|---|---|
| Public title | A Clinical Study to evaluate Efficacy and Safety of Tapentadol Nasal Spray in Comparison to Tramadol in Patients with Post-Operative Pain |
| Scientific title | A Multicentric, Randomized, Open Label Clinical Trial to Evaluate Efficacy and Safety of Tapentadol Nasal Spray in Comparison to Tramadol Immediate Release Capsule and Intravenous Injection in Patients with Post-Operative Moderate to Severe Pain |
| Primary sponsor | Torrent Pharmaceutical Ltd |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: O- Medical and Surgical |
| Interventions | Intervention1: Tapentadol: Nasal Spray 22.5 mg/45 mg every 4-6 hours for 05 days Control Intervention1: Tramadol: Injection 50mg/100mg every 4-6 hours for 1 day or 2 day Capsule 50mg/100mg every 4-6 hours for remaining 03/04 days |
| Registration date | Mar 18, 2019 |
| Target size | 294 |
| Secondary IDs | CT/TAPE/PAIN/17/03 Version 2.1 21/12/2018 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: